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Abstract
Background: We aimed to investigate podiatry practice in diagnosing peripheral arterial disease (PAD) in diabetes,
decision making once PAD is suspected and limitations of referral pathways.
Methods: A survey, comprising 26 questions was distributed to podiatrists across the UK via mailing lists of
collaborating organizations including the College of Podiatry (UK). Response rates were estimated based on NHS
workforce data. Analysis of responses from the open-ended questions was performed using inductive content analysis.
Results: Data from 283 respondents were analyzed. Response rate for all NHS podiatrists across the UK was estimated
to be 6%. For the detection of arterial disease only 18.8% (n = 49/260) of participants reported using a full combination
of history, pulse palpation, Doppler and ABPI assessment. Self-reported confidence in detecting arterial disease was
highest amongst podiatrists who felt they had received adequate training compared to podiatrists who felt they had
not (median 85 (IQR 75–90) vs 67 (50–77), respectively; p < 0.001) as well as those who see > 20 diabetic patients per
week compared to those who see < 20 (median 80 (IQR 70–90) vs 72 (60–82.8), respectively; p < 0.001). Over one third
of respondents (35.8%, n = 93/260) were aware of missed cases of PAD in the past year and 17.5% (n = 38/217)
believed that this resulted in an amputation in some cases.
The survey highlighted a lack of clarity amongst podiatrists regarding referral guidelines. Additionally, 69% (n = 169/242)
reported that their patients had to wait longer than 2-weeks for specialist vascular assessment and 67.6% (n = 54/80)
reported similar waits for a Duplex Ultrasound scan. There was a statistically significant variation in DUS waiting time
across the UK (X2 (10, N = 80) = 21.59, p = 0.017). Inability to make a direct referral to vascular services and long delays
were reported as major limitations of the referral pathway.
Conclusion: We have identified important targets for further investigation and quality improvement.
Keywords: Macrovascular disease, Diabetic foot, Health care delivery
Background
Prevention and management of diabetic foot ulceration
requires complex, well-coordinated multidisciplinary
care across all healthcare settings as recommended by
the National Institute of Health and Care Excellence
(NICE) and the ‘Putting Feet First’ National Framework
[1, 2]. This care pathway is structured to include a ‘Foot
Protection Team (FPT)’ to work in the community,
comprising healthcare professionals, often podiatrists, with
specialist expertise in diabetic foot assessment and man-
agement. The FPT work closely with a ‘Multidisciplinary
Foot Care Team (MDFT)’ who manage diabetic foot
problems in hospitals as well as more complex cases
in the community.
Regular assessment of vascular status by the FPT is of
utmost importance in the management of the diabetic
foot to detect the presence of peripheral arterial disease
(PAD). PAD is a major risk factor for the development
of ulceration, amputation and overall mortality [3]. The
detection of PAD in the non-ulcerated foot allows for
correct identification of risk status and ulcer prevention.
* Correspondence: p.normahani@imperial.ac.uk
1Department of Vascular Surgery, Imperial College NHS Healthcare Trust,
London, UK
5Department of Vascular Surgery, Hammersmith Hospital, Du Cane Road,
London W12 0HS, UK
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Normahani et al. Journal of Foot and Ankle Research  (2018) 11:29 
https://doi.org/10.1186/s13047-018-0270-5
Furthermore, it provides an important opportunity to
modify cardiovascular risk factors, which may impact
positively on mortality rates [4]. Moreover, the prompt
and accurate detection of PAD in the ulcerated foot is
even more time critical as time to revascularisation is a
determinant of ulcer healing and limb salvage [5, 6].
With late diagnosis of PAD, consideration of revasculari-
sation is delayed and hence often unsuitable due to pro-
gression of tissue loss or infection [7–10]. Reported
delays to vascular assessment and intervention in the lit-
erature negatively affect patient outcomes [11, 12].
Time to revascualrisation is potentially influenced by
several variables including factors related to the patient
(e.g. delay to presentation), health provider (e.g. delay in
diagnosis, deficiency in knowledge and training) and
health care system (e.g. referral pathways, waiting lists,
staffing). Current national data sets from England, pro-
vide very little information regarding practice patterns in
PAD diagnosis, decision making once PAD is suspected
and the status of vascular surgery referral pathways [13].
In this national survey of podiatry practice in the United
Kingdom (UK), we aimed to investigate current practice
in diagnosing PAD in diabetes, decision making once
PAD is suspected and limitations of referral pathways.
This may help identify potential targets for further inves-
tigation and quality improvement. We have focused spe-
cifically on podiatry practice, as podiatry practice is the
link between diabetic patients and diabetic foot care.
Methods
A survey comprising of 26 questions was drawn up
(Additional file 1: Figure S1). Questions were generated
following literature review and discussion with a collab-
orative faculty including a podiatrist, podiatric surgeon
and two vascular surgeons within our network. Follow-
ing completion of the survey one question (“which pa-
tients do you routinely screen for peripheral arterial
disease (PAD)?”) was removed as it was felt to be vague.
The remaining 25 questions were split into four
categories: Demographics (7 questions); PAD assessment
(7 questions); Vascular referrals (11 questions) (Additional
file 1: Figure S1). Using online survey software (https://
www.surveymonkey.co.uk) a link to questions was sent to
mailing lists of the College of Podiatry (UK), alumni net-
works of major podiatry schools in the UK and local po-
diatry networks as well as relevant social media contacts
of the authors between July to September 2016. A re-
minder email was sent two months following the first
email to improve the response rate.
Estimating response rates
As many of the survey invitations were sent by collabor-
ating organisations, response rate could not be formally
established or estimated based on how many podiatrists
were in each group as this information was not always
available. Therefore, we used NHS workforce statistics
to estimate response rates and determine how represen-
tative the respondents were in terms of geographical
spread. In order to establish the number of podiatrists in
post across the UK, a number of reports were used;
NHS England (July 2016) [14, 15], NHS Scotland (June
2016) [16], NHS Wales (September 2016) [17] and NHS
Northern Ireland (March 2016) [18]. Detailed informa-
tion regarding podiatrist demographics (banding) was
only available from NHS England data, and so this was
used to determine how representative the respondents
were in terms of experience. Response rates for podia-
trists working in the private sector could not be esti-
mated due to a lack of available data regarding the size
of the workforce.
Statistical and qualitative analysis
Responses to the survey were downloaded and analyzed
using Excel (Microsoft, Redmond, USA) and SPSS
version 23 (IBM, New York). Continuous data demon-
strated a non-normal distribution. Mann-Whitney U test
was used to compare groups of continuous data. Cat-
egorical data were compared using Chi-squared test. Cut
offs used for group comparisons (e.g. comparisons made
between podiatrists seeing < 20 patients per week as
compared to those seeing > 20 per week) were predeter-
mined based on what was felt to be clinically relevant. A
p-value of < 0.05 was considered statistically significant.
Analysis of responses from the open-ended questions
was performed using inductive content analysis [19].
This involved reading all responses (author PN) and
freely generating categories to describe all aspects of the
content. Categories were named using content charac-
teristic words and these were expanded into subcategor-
ies with similar themes. Using this abstraction method, a
general description of responses could be created.
Results
Demographics
There were two hundred and eighty six respondents.
Three non-podiatrist respondents were removed from the
survey (two Vascular Nurse Specialists and a Vascular
Scientist). The remaining data from 283 respondents were
analyzed. Demographic data of respondents are presented
in Table 1. Not all participants completed all of the ques-
tions in the survey. Therefore, the total number of respon-
dents for each question is given in brackets (‘n=’) and
percentages calculated using this denominator.
We estimate that the response rate from NHS podia-
trists across the country was approximately 6%. This is
based on an estimated number of 3791 podiatrists work-
ing in the NHS across the UK around the time of the
survey and the 239 NHS podiatrist respondents.
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When comparing the geographical spread of respon-
dents to the spread of podiatrists across the UK, we note
an underrepresentation of the North East (1.1% vs 5.7%,
respectively), West Midlands (2.5% vs 8.1%) and
Northern Ireland (1.4% vs 5.6%) and an over representa-
tion of London (13.8% vs 9.6%) and the South East (18%
vs 6.7%) (Additional file 2: Table S1).
We also compared the distribution of the respondents ex-
perience to the distribution across England and found an
over representation of band 6–7 podiatrists (74.2% vs 42.9%,
respectively) as well as an under representation of band 4–5
(14.4% vs 20.7%) and band 8–9 podiatrists (20.8% vs 36.3%).
Assessment for arterial disease in diabetes
Podiatrists were confident in their ability to detect PAD in
diabetes with a mean self-assessed confidence score of 76
(SD ± 16.8, n = 260) on a scale of 0 (least confident) to 100
(most confident). Podiatrists who see more than 20 patients
per week were more confident in their ability to detected
PAD compared to those who see less than 20 patients per
week (median 80 (IQR 70–90) vs 72 (60–82.8), respectively;
p < 0.001). Most felt that they had received adequate train-
ing in PAD detection (Yes, 63.5%; No, 23.5%; Unsure,
13.1%. n = 260). Those who felt they had received adequate
training were more confident in their ability to detect PAD
compared to those who felt they had not (median 85 (IQR
75–90) vs 67 (50–77), respectively; p < 0.001).
Respondents were asked regarding routinely performed
PAD screening tests used in clinical practice and their rela-
tive importance in clinical decision-making (on a scale of 1
to 5: 1, not at all important; 2, not important; 3, unsure; 4,
important; 5, very important). Their responses are pre-
sented in Figs. 1 and 2. Toe brachial pressure index (TBPI)
and Transcutaneous pressure of oxygen (TcPO2) were sel-
dom used in clinical practice (6.2 and 0.8% respectively)
and were also scored as least important in clinical
decision-making (3.4 and 3.2 respectively). A minimum
combination of history and pulse palpation was used for
PAD assessment by 96.2% of respondents (n = 260). In
addition to history and pulse palpation at least one other
non-invasive test was also used by 85.8% (n = 260). As the
demonstrated in Table 2, the most common combination
of tests, used by 60% of all respondents, was that of history,
pulse palpation and audible Doppler waveform assessment.
The second most common combination, used by 18.8% of
all respondents, was that of history, pulse palpation,
Doppler assessment and ABPI. There was a statistically sig-
nificant association between region of work and the various
combinations of tests used (X2 (121, N = 260) = 153.36,
p = 0.025) (Table 2), with more than a third of re-
spondents from East of England, North East and
West Midlands using history, pulse palpation and at
least two other non-invasive tests. There was no sig-
nificant association between combination of tests used
Table 1 Demographics
Occupation (n = 283)
Podiatrist 274 (96.8%)
Podiatry consultant 7 (2.5%)
Podiatry assistant 2 (0.7%)
How many years have you worked in this capacity? (n = 283)
< 5 years 71 (25.1%)
5–10 years 50 (17.7%)
> 10 years 162 (57.2%)
Which sector do you work in? (n = 281)
NHS 239 (85.1%)
Private 42 (14.9%)
What is your banding? (n = 236)
Band 4 1 (0.4%)
Band 5 31 (13.1%)
Band 6 89 (37.7%)
Band 7 86 (36.4%)
Band 8 27 (11.4%)
Band 9 2 (0.8%)
In which region of the UK do you work? (n = 283)
East 11 (3.9%)
East Midlands 8 (2.8%)
London 39 (13.8%)
North East 3 (1.1%)
North West 42 (14.8%)
Northern Ireland 4 (1.4%)
Scotland 45 (15.9%)
South East 51 (18%)
South West 21 (7.4%)
Wales 23 (8.1%)
West Midlands 8 (2.8%)
Yorkshire and the Humber 28 (9.9%)
How many diabetic patients do you see per week? (n = 283)
None 4 (1.4%)
< 5 22 (7.8%)
5–10 30 (10.6%)
10–20 45 (15.9%)
> 20 182 (64.3%)
How long is your typical appointment slot? (n = 283)
0–10 min 2 (0.7%)
10-20 min 59 (20.9%)
20–30 min 176 (62.2%)
> 30 min 46 (16.3%)
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and the number of patients seen per week (X2 (11,
N = 260) = 8.27, p = 0.69) or the perception of training
adequacy (X2 (22, N = 260) = 13.69, p = 0.91).
When asked whether ABPI (ABPI; < 0.9 considered ab-
normal) is a reliable method to exclude PAD in diabetes,
most respondents felt that it was not (Yes 20%, No
57.7%, Unsure 22.3%; n = 260).
When podiatrists were asked whether in the past year
they were aware of patients with diabetes who were
diagnosed with PAD that had been previously missed,
Fig. 1 Bar chart representing responses to question “Which of the following do you routinely perform as part of your screening (tick all that
apply) for PAD?”. Doppler: audible hand held Doppler waveform assessment; ABPI: ankle brachial pressure index; TBPI: toe brachial pressure index;
TcPO2: transcutaneous oxygen pressure
Fig. 2 Bar chart representing responses to question “Please score the following options to indicate their importance to your clinical decision
making.” Doppler: Audible hand held Doppler waveform assessment; ABPI: Ankle brachial pressure index; TBPI: Toe brachial pressure index; TcPO2:
Transcutaneous oxygen pressure. SD(Standard deviation). Scored on a scale of 0 to 5; 0: not at all important; 1: not important; 2: unsure; 3:
important; 5: very important
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over a third of respondents reported that they were
aware of such cases (Yes 35.8%, No 35.8%, Unsure
28.5%; n = 260). There was no statistically significant
association between the perception of missed PAD de-
tection and the region of work (X2 (22, N = 260) = 21.70,
p = 0.48) or the combination of tests used in PAD
screening (X2 (22, N = 260) = 18.65, p = 0.67). We went
on to ask whether delayed detection of PAD in any of
these cases had led to a minor or major amputation, to
which 17.5% responded that it had, 33.8% responded
that it had not and 49.3% were unsure (n = 217).
Vascular referral pathways
When podiatrists were asked if they had access to advice
from a vascular surgeon via a MDFT, a large proportion
responded that they did not (Yes 59.4%, No 36.4%, Unsure
4.4%; n = 283). There was no association between access to
vascular advice and region of work (X2 (22, N = 283) = 28.2,
p = 0.17). However, there was a statistically significant
association between access to vascular advice and the
number of patients seen per week (X2 (2, N = 283) = 26.50,
p < 0.001); 70% of podiatrists who see more than 20 pa-
tients per week reported having access to vascular advise
as compared to 40% of podiatrists who see less than 20
patients per week.
In a multiple-choice question, most respondents re-
ported that they would refer ‘any patient with suspected
PAD and diabetes for further assessment’ (59.4%, n = 256).
Amongst the remaining respondents (n = 104) the most
common triggers for vascular referral were active ulcers
and non-healing ulcers (Fig. 3). On further analysis, 43
(16.8%) respondents reported that they would only refer
patients with PAD who had non-healing ulcers despite
6-weeks of optimal management.
In terms of volume of referrals, respondents reported
on average referring six patients (SD ±16.5, n = 225) per
month or 41 patients (SD ± 63.4) per year (n = 207).
The reported waiting times for vascular review are pre-
sented in Fig. 4. Most respondents felt that waiting times
for vascular assessment were too long (appropriate wait-
ing time 28.1%, too long 50.4%, unsure 21.5%; n = 242).
There was no statistically significant association be-
tween reported vascular waiting times (groups com-
pared: > 4 weeks or < 4 weeks) and the number of patients
seen per week (groups compared: > 20 patients per week
or < 20 patients per week) (X2 (1, N = 242) = 1.05, p = 0.19)
or with the region of work (X2 (11, N = 242) = 17.33,
p = 0.10).
When asked whether they always receive the outcome
of the vascular consultation, the majority reported that
they do not (yes 28.1%, no 71.9%; n = 256). This was not
associated with the number of patients seen per week
(X2 (1, N = 256) = 0.53, p = 0.28) or the region of work
(X2 (11, N = 256) = 14.95, p = 0.19).
When asked what proportion of patients referred to
Vascular Surgery over the past year required vascular
Fig. 3 Bar chart representing responses to question “If you suspect PAD in a patient with diabetes, when would you refer for further Vascular
assessment?” (multiple choice). Respondents who reported that they would refer ‘any patient with suspected PAD and diabetes for further
assessment’ have been excluded from this graph. Active ulcer; if there is any active foot ulceration. Non-healing ulcer; if there is an ulcer that has
not improved within 6-weeks despite optimal management. Infection; if there is evidence of infection. Prior to debridement; if they need
local debridement
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intervention, responses were mixed: < 10, 19.4%; 10–25,
16.1%; 25–50, 19%; 50–75, 26%; > 75, 19.4%.
Most of those surveyed reported that they were unable
to request a Duplex Ultrasound (DUS) directly (Yes
20.6%, no 69.4%, unsure 9.9%; n = 242). The average
waiting times, for those who could, are presented in
Fig. 4. Most respondents felt that the waiting times were
too long (appropriate waiting time 26.6%, too long 42.6%,
unsure 30.9%; n = 90). There was no statistically significant
association between the ability to request a DUS and number
of patients seen per week (X2 (2, N= 242) = 4.11, p= 0.13) or
the region of work (X2 (22, N= 242) = 30.21, p= 0.11). How-
ever, there was a statistically significant association be-
tween duration of wait (> 4 weeks or < 4 weeks) and the
region of work (X2 (10, N = 80) = 21.59, p = 0.017). A large
number of respondents reported waiting times of less
than 4 weeks in London (84.6% reported waiting
times of < 4 weeks, n = 13), North West (85.7% < 4 weeks,
n = 14), South East (91.7% < 4 weeks, n = 12), North East
(100% < 4 weeks, n = 2), East Midlands (100% < 4 weeks,
N = 1), West Midlands (100% < 4 weeks, n = 1) and
Yorkshire (87.5% < 4 weeks, n = 8). Conversely, a
larger proportion of respondents reported waiting
times > 4 weeks in East (66.7% waited > 4 weeks, n = 3),
South West (66.7% > 4 weeks, n = 6) and Wales
(63.6% > 4 weeks, n = 11). There was a mixed response
from Scotland (55.6% < 4 weeks, n = 9).
In an open-ended question, we asked podiatrists what
they thought the biggest limitations were in their vascu-
lar referral pathway; the abstraction process used in
qualitatively analysing these responses is presented in
Fig. 5 and sample quotes for each subdomain presented
in Additional file 3: Table S2.
Discussion
To our knowledge, this is the first survey to specifically
evaluate national trends in PAD diagnosis in diabetes,
decision-making when PAD is suspected and vascular
referral pathways in detail. Although the results must be
interpreted cautiously in the context of the studies limi-
tations, they present important targets for further inves-
tigation and quality improvement. This may in turn
result in improved PAD detection and a more efficient
vascular referral pathway. This is becoming increasingly
important with the worldwide epidemic of type 2
diabetes, which will only result in a rising prevalence of
diabetic foot ulcers and a significant demand on our
already strained healthcare system [20].
Assessment for arterial disease in diabetes
Current training recommendations for podiatrists en-
dorse history, pulse palpation with or without audible
Doppler waveform assessment and ABPI as part of the
standard assessment for arterial insufficiency [2]. This is
Fig. 4 Stacked bar chart representing responses to the following two questions: “on average how long do your patients have to wait for a
Vascular assessment by a vascular surgeon?” and a follow on question for those who can directly request a duplex ultrasound (DUS) “if yes, how
long does it take to have a duplex ultrasound performed?”
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supported by guidance from the International Working
Group on the Diabetic Foot (IWGDF) who recommend,
at minimum, a combination of history and pulse palpa-
tion in patients without active foot ulceration, and the
additional use of ABPI and the assessment of arterial
waveforms in those with ulceration [21]. The majority of
respondents to our survey (96%) reported using a mini-
mum combination of history and pulse palpation in
PAD assessment. Although 86% reported using at least
one additional non-invasive test (most commonly aud-
ible waveform assessment) very few used a complete
combination of history, pulse palpation, Doppler wave-
form assessment and ABPI (18.8%). So although compli-
ance with the minimum IWGDF guidance is met,
complete compliance is very poor. We also found signifi-
cant variation in the regions of the UK regarding what
combinations of tests were used. The reason for this vari-
ation is not clear and may warrant further investigation.
Over one third of respondents were aware of missed
cases of PAD in people with diabetes over the past year.
Of concern was the large number of responses indicat-
ing that, in some cases, this incorrect diagnosis had con-
tributed to a minor or major amputation. This is seldom
reported in the scientific literature but there are a small
number of retrospective studies which have highlighted
delayed vascular referral as a cause of limb loss [11, 22].
Although the exact causes of delay are not clear from
these studies, our results suggest that missed diagnosis
may be a contributing factor in some cases.
Surveyed podiatrists felt confident in detecting PAD in
diabetes and the majority (64%) felt they had received ad-
equate training in PAD detection. However, a sizable pro-
portion (23.5%) of respondents reported that they have not
received adequate training in PAD detection and this may
be a potential target for further investigation and quality
improvement. Unsurprisingly, we found that confidence
was higher in those who had a higher volume of diabetic
foot practice and also those who felt they had received ad-
equate training. It is not clear from this survey how much
PAD assessment training respondents received as under-
graduates. Regardless, there is also a need to maintain pro-
fessional competencies after graduation and so therefore
postgraduate training is also important. Our survey sug-
gests that this may be most relevant for podiatrists with a
low volume of diabetic foot practice (< 20 patients per
week) and so therefore, the amount of postgraduate train-
ing may be tailored to volume of practice. Another option
would be to audit the accuracy of PAD assessments locally
and tailor training accordingly. In the National diabetes
foot care audit (England) less than 60% of clinical commis-
sioning groups (CCGs) could confidently say that there is
training provided locally for those preforming foot checks
[13]. It is not clear how much of this training is provided
to podiatrists specifically and what the training entails.
Due to the confounding effects of neuropathy and
arterial calcification, the detection of PAD in diabetes
can be challenging and this must be also considered
when discussing delayed or missed diagnosis [23].
Fig. 5 Schematic diagram of abstraction process for responses to the open question “in your opinion, what are the biggest limitations in your
vascular referral pathway?”. MDFT; multidisciplinary team
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Respondents in our survey placed high importance on
history and pulse palpation in detecting PAD. Neur-
opathy can mask symptoms of claudication and rest pain
whilst arterial calcification hinders palpation of foot
pulses [24]. Pulse palpation is also limited by substantial
inter-observer variation [25, 26]. High importance is also
placed on audible waveform assessment using a hand-
held Doppler. However, this has a has a poor sensitivity
(as low as 43%) in patients with diabetes as well as poor
inter- and intra- observer reliability [27, 28].
IWGDF guidelines recommend the use of ABPI meas-
urement in the assessment of the diabetic foot. They rec-
ommend considering ABPI measurements of less than 0.9
as abnormal and those between 0.9–1.3 as largely exclud-
ing PAD (GRADE recommendation: strong; Quality of
evidence: low) [21]. Although, it is widely accepted that
low values (< 0.9) are useful in detecting arterial disease,
evidence suggests that high values (0.9–1.3 or > 1.3)
cannot reliably exclude PAD in the presence of diabetes
[29, 30]. This is because measurements can be falsely ele-
vated due to the presence of incompressible calcified
blood vessels [29]. Although this is acknowledged in the
rationale for the IWGDF recommendation, confusingly it
has still been retained in the guidance that a value be-
tween 0.9–1.3 can exclude PAD. Participants in our survey
demonstrated poor knowledge of ABPI interpretation with
44.3% either falsely considering that ABPI is a reliable
method to exclude PAD in diabetes or being uncertain.
They also demonstrated poor knowledge of the usefulness
of ABPI with only 26% of respondents routinely perform-
ing it in clinical practice. These results suggest that
IWGDF guidance may need to be reviewed in order to
clarify this issue.
Due to limited data and poor methodological quality
of studies, there is currently little evidence to support
the use of any one non-invasive diagnostic modality over
another [29]. However, limited evidence suggests that
TBPI and TcPO2 may be superior to ABPI measure-
ments [29, 31]. In our cohort of respondents these were
seldom used in clinical practice (6.2 and 0.8% respect-
ively) and were also scored as least important in clinical
decision-making. Our result suggest that there is an
under utilisation of TBPI and TcPO2 as part of the full
PAD assessment.
Unfortunately, as part of this survey we did not ex-
plore respondents technique in performing ABPI and
audible Doppler waveform assessments or the cutoff
thresholds for Doppler assessment.
Vascular referral pathways
Once PAD is suspected a decision must be made as to
whether it is appropriate to refer for further vascular
evaluation. This is a contentious topic and a common
source of confusion amongst health care professionals.
The IWGDF has recommended considering further vas-
cular imaging and revascularisation in patients with a foot
ulcer and critical limb ischaemia (toe pressure < 30 mmHg,
TcPO2 < 25 mmHg) and those with a non-healing foot
ulcer and evidence of PAD (ankle pressure < 50 mmHg or
ABPI < 0.5). They have also recommended to consider
vascular imaging and subsequent vascular interven-
tion, irrespective of the results of bedside tests, when
an ulcer does not heal within 6-weeks despite optimal
management [10, 21].
In this survey, 60% of respondents reported that they
would refer any patient with suspected PAD and dia-
betes for further vascular assessment regardless of ulcer
status. Routine referral of patients with suspected PAD
but no evidence of tissue loss is not recommended in
current guidelines and may increase demand on vascular
services. In the presence of PAD, 16.8% of respondents
reported that they would only refer non-healing ulcers
after 6-weeks of conservative treatment, which could re-
sult in significant delay in management. Many respon-
dents also reported that they would not refer for further
vascular assessment prior to local debridement in cases
of suspected PAD. This practice could be risky, as de-
bridement of an ischaemic foot may fail to heal.
These results highlight a need for better collaborative
working between vascular and podiatry services to clarify
guidelines at a local level and ensure all healthcare pro-
viders are aware of them.
In practice, if a functional MDFT with vascular pres-
ence is established then vascular review can be arranged
in a timely manner. However, in our survey over one
third of respondents reported not having access to a
vascular surgeon via a MDFT. This is in keeping with re-
ports of wide variation in regional foot care services in
the UK [13, 32]. We have not established what propor-
tion of our respondents work in the community, which
may influence responses to this question. Our results
did however suggest that podiatrists seeing higher vol-
ume of patients were more likely to have access to a vas-
cular surgeon via an MDFT, which suggests that this is a
problem predominantly effecting lower volume clinics. It
is important to note that at present there is no common
agreement on what the minimum requirement is in
terms of specialty presence in a MDFT and therefore it
is not mandatory to have vascular presence [33]. Al-
though universal vascular presence in the MDFT would
improve access to specialist advice, analyses of open-ended
responses in our survey suggest that a shortage of
vascular surgeons may be a potential barrier that war-
rants further exploration.
When referrals have been made, almost 70% reported
that their patients wait longer than 2-weeks for assess-
ment, with the majority waiting longer than 4-weeks.
Long delays, lack of capacity and too few clinics were
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often reported as major limitations of the vascular refer-
ral pathway. In the open responses, some podiatrists
clarified that ulceration increased speed of referrals al-
though others noted that this was not the case.
Another important finding of the present survey is the
commonly perceived difficulties with the vascular referral
process. There is a collective frustration with the inability
to refer directly to vascular clinics, with most podiatrists
having to refer via the patient’s general practitioner, which
can be a further source of delay. To add to this frustration,
some of those who could make direct referrals felt that
the referral process was unclear or too complicated.
Surprisingly, over 70% of respondents reported that
they do not receive regular feedback of outcomes from
vascular consultations. This is reflective of the number
who highlighted poor communication as a limitation of
the vascular referral pathway. This may be because refer-
rals are being initiated via the patient’s general practi-
tioner who is then receiving assessment outcomes. Our
results demonstrate that not all vascular referral path-
ways in the UK are meeting the expected standards of a
‘coordinated team approach’ to foot care. This again
highlights a need for better collaborative working be-
tween vascular and podiatry services and improvement
in referral pathways.
Arguably the most important step in deciding whether
elective revascularisation is technically feasible or not is
to obtain anatomical imaging. DUS is most often the
first imaging modality of choice. Current guidelines rec-
ommend anatomical imaging whenever PAD is sus-
pected and when it is not suspected but the ulcer has
not healed despite 6-weeks of conservative treatment
[21]. The Eurodiale study highlighted significant defi-
ciencies in obtaining vascular imaging across Europe
[12]. In patients diagnosed with PAD on initial vascular
assessment (TcPO2, ABPI, TBPI), only 41% underwent
anatomical imaging. In patients who did not heal after a
follow up of 1-year or patients who underwent major
amputation, vascular imaging was only performed in
40%. Overall, the UK had one of the lowest rates of vas-
cular imaging when compared to other countries. In our
survey, most respondents reported that they were unable
to directly request a DUS and those who could were
faced with long waiting times. We also found that there
were differences in waiting times depending on the re-
gion of work. The reasons for this deficiency are unclear
but may be related to funding, a shortage of trained staff
and organisational barriers.
Study limitations
The present study has a number of important limita-
tions and the results should be interpreted cautiously.
Firstly, although the survey was developed with
multidisciplinary input its validity and reliability were
not assessed.
Secondly, we have surveyed only a small proportion
of podiatrists across the UK and as demonstrated there
are some differences in terms of geographical spread
and demographics when compared to podiatrists na-
tionally. Furthermore, we received a relatively small
number of responses from podiatrists in the private
sector and it is unclear if this is representative of the
overall profession or whether it’s a result of survey dis-
tribution or response bias. Additionally, not all respon-
dents completed all of the questions in the survey,
resulting in missing data. These factors also led to some
difficulties in regional subgroup analysis due to small
group sizes that may have resulted in a type II error.
Thirdly, responses to surveys can be very subjective and
this must be considered when interpreting results. Finally,
although survey studies can be powerful in highlighting
what happens in clinical practice, detailed analysis is often
not possible. Examples of this in the present study include
the inability to ascertain the details surrounding the
missed cases of PAD reported by respondents and the in-
ability to retrospectively determine in what setting the
podiatrist worked (community or hospital).
Conclusions
This survey has highlighted poor compliance with
guidelines relating to arterial disease detection in dia-
betes, poor utility of non-invasive tests such as (specif-
ically ABPI, TBPI and TCO2) and a poor knowledge of
ABPI interpretation amongst podiatrists in the UK.
We have also highlighted a lack of clarity amongst UK
podiatrists regarding referral guidelines with many
referring any patient with suspected PAD for further
vascular assessment.
Additionaly, we have also highlighted that within the
UK there is a lack of access to vascular surgeons via
MDFT’s, particularly for those podiatrists seeing a lower
volume of patients, lack of ability to make direct referrals
for onwards vascular assessment, lack of feedback regard-
ing vascular assessment outcome and long waiting times
for vascular review and DUS imaging.
The above findings are important targets for further
investigation and quality improvement.
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